Two advisory committees of the US Food and Drug Administration (FDA) met jointly to discuss a safety review of neuropsychiatric events in children taking montelukast (Singulair, Merck) for asthma and ...
Montelukast is also used to treat symptoms of year-round perennial allergies in adults and children who are at least 6 months old. Montelukast is not expected to be harmful to an unborn baby. Tell ...
Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included ...
(CNN) --The US Food and Drug Administration announced Wednesday it is requiring a boxed warning -- the agency's most prominent warning -- for asthma and allergy medication montelukast, sold under the ...
The Nonprescription Drugs Advisory Committee of the US Food and Drug Administration (FDA) has voted against recommending that montelukast (Singulair Allergy, Merck) be approved as an over-the-counter ...
Despite concerns about its possible side effects, Western Pennsylvania doctors say some patients can remain on Singulair to relieve asthma or allergy symptoms. But in most cases, the doctors say they ...
A new study on a drug widely prescribed for asthma is binding itself to receptors in the brain and is linked to severe mental health issues and suicide, according to new research. The Food and Drug ...
Montelukast belongs to a class of drugs known as leukotriene receptor antagonists, and is used in mild to moderate asthma to decrease the symptoms of asthma. Singulair is used in the long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results